WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013055385) METHODS OF TREATING AGE RELATED DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/055385    International Application No.:    PCT/US2012/000461
Publication Date: 18.04.2013 International Filing Date: 03.10.2012
IPC:
A61K 31/336 (2006.01), A61K 31/7088 (2006.01), A61K 31/713 (2006.01), A61K 39/00 (2006.01), A61P 39/06 (2006.01), A61P 39/00 (2006.01), A61P 19/02 (2006.01), A61P 19/00 (2006.01), A61P 3/04 (2006.01), A61P 25/00 (2006.01), A61P 25/24 (2006.01), A61P 25/28 (2006.01), A61P 9/00 (2006.01), A61P 21/00 (2006.01)
Applicants: ZAFGEN CORPORATION [US/US]; One Broadway, 8th Floor Cambridge, MA 02142 (US).
HUGHES, Thomas, E. [US/US]; (US).
VATH, James, E. [US/US]; (US)
Inventors: HUGHES, Thomas, E.; (US).
VATH, James, E.; (US)
Agent: KAVANAUGH, Theresa, C.; Goodwin Procter LLP Exchange Place Boston, MA 02109 (US)
Priority Data:
61/542,393 03.10.2011 US
Title (EN) METHODS OF TREATING AGE RELATED DISORDERS
(FR) MÉTHODES DE TRAITEMENT DE TROUBLES LIÉS À L'ÂGE
Abstract: front page image
(EN)The invention generally relates to methods of treating a patient having, and/or at risk of, oxidative distress disorders and/or age-related disorders. The disclosure also generally relates to methods of treating memory impairment or enhancing the cognitive function of a patient in need thereof. Such methods may include administering a therapeutically effective amount of a MetAP2 inhibitor.
(FR)La présente invention concerne de manière générale des méthodes de traitement d'un patient atteint, et/ou à risque pour développer des troubles liés au stress oxydatif et/ou à l'âge. L'invention concerne également de manière générale des méthodes de traitement de déficiences de la mémoire ou d'amélioration de la fonction cognitive d'un patient ayant besoin d'un tel traitement. De telles méthodes peuvent comprendre l'administration d'une quantité thérapeutiquement efficace d'un inhibiteur de la MetAP2.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)